Research Associate in Topological Data Analysis for Cell Biology SALARY: From £39,500 per annum (depending on skills and experience) LOCATION: Didcot, Oxfordshire JOB TYPE: 2 Year Fixed Term Contract (with the possibility of extension) The Role The Rosalind
Research Associate in In Vitro Models of Early Development SALARY: from £39,500 per annum (depending on skills and experience) JOB TYPE: 2 Year Fixed-Term, Full-Time Contract About us The Rosalind Franklin Institute (the Franklin) is a
Research Associate in Machine-Learning Modelling of 2-D and 3-D Images SALARY: From £39,500 per annum (depending on skills and experience) LOCATION: Didcot, Oxfordshire JOB TYPE: 2 Year Fixed Term Contract (with the possibility of extension) The
Postdoctoral Researcher in Quantitative Cell Biology/Biochemistry SALARY: From £39,500 per annum (depending on skills and experience) + Benefits JOB TYPE: Full-Time, 18 Months Fixed-Term Contract (with the possibility of extension) LOCATION: Didcot, Oxfordshire The Rosalind Franklin Institute
Laboratory Technician SALARY: From £29,300 per annum (depending on skills and experience) JOB TYPE: 2 Year, Full-Time, Fixed Term Contract (with the possibility of extension) LOCATION: Didcot, Oxfordshire About us The Rosalind Franklin Institute (the Franklin)
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in
Manager, Quality Systems - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology,
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet